EUVIMEDEUVIMED entdecken
Crossref

Optimizing real‐world evidence studies for regulatory decision‐making and impact assessment in pharmacovigilance

Ignatios Ioakeim-Skoufa iD, Kerry Atkins iD, Miguel Ángel Hernández-Rodríguez iD

British Journal of Clinical Pharmacology · 2025-04 · 91 (4) · 1092-1095

DOI: 10.1111/bcp.16393 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 17.01.2025. Verfasst von Ignatios Ioakeim-Skoufa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Statistics, Division of Health Data and Digitalisation, Norwegian Institute of Public Health, Oslo, Norway. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

databasesdrug evaluationdrug information servicespharmacovigilancereal‐world evidenceregulatory decision‐making

Autor:innen und Institutionen

  • Department of Drug Statistics, Division of Health Data and Digitalisation, Norwegian Institute of Public Health, Oslo, Norway.
  • Emerging Technologies Advisory Group, ISACA, Schaumburg, Illinois, USA.
  • EpiChron Research Group on Chronic Diseases, Aragon Health Sciences Institute (IACS), Aragon Health Research Institute (IIS Aragón), Miguel Servet University Hospital, Zaragoza, Spain.
  • Drug Utilisation Work Group, Spanish Society of Family and Community Medicine (semFYC), Barcelona, Spain.
  • Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), Institute of Health Carlos III (ISCIII), Madrid, Spain.
  • Department of Pharmacology, Physiology, and Legal and Forensic Medicine, Faculty of Medicine, University of Zaragoza, Zaragoza, Spain.

ORCID-Profile: Ignatios Ioakeim-Skoufa, Kerry Atkins, Miguel Ángel Hernández-Rodríguez

Zitieren

APA

Ioakeim-Skoufa, I., Atkins, K., & Hernández-Rodríguez, M. Á. (2025). Optimizing real‐world evidence studies for regulatory decision‐making and impact assessment in pharmacovigilance. British Journal of Clinical Pharmacology, 91(4), 1092-1095. https://doi.org/10.1111/bcp.16393

Vancouver

Ioakeim-Skoufa I, Atkins K, Hernández-Rodríguez MÁ. Optimizing real‐world evidence studies for regulatory decision‐making and impact assessment in pharmacovigilance. British Journal of Clinical Pharmacology. 2025;91(4):1092-1095. doi:10.1111/bcp.16393

BibTeX
@article{IoakeimSkoufa2025,
  author = {Ioakeim-Skoufa, Ignatios and Atkins, Kerry and Hernández-Rodríguez, Miguel Ángel},
  title = {Optimizing real‐world evidence studies for regulatory decision‐making and impact assessment in pharmacovigilance},
  journal = {British Journal of Clinical Pharmacology},
  year = {2025},
  volume = {91},
  number = {4},
  pages = {1092--1095},
  doi = {10.1111/bcp.16393}
}
Kostenlos starten →